AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 84 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $231,000 | -96.3% | 24,236 | -96.8% | 0.02% | -96.4% |
| Q3 2015 | $6,167,000 | -29.3% | 748,420 | +39.3% | 0.47% | -34.7% |
| Q2 2015 | $8,725,000 | -48.9% | 537,282 | +27.6% | 0.72% | -53.3% |
| Q1 2015 | $17,064,000 | -54.8% | 421,133 | -39.8% | 1.53% | -62.7% |
| Q4 2014 | $37,750,000 | +75.3% | 699,070 | -0.1% | 4.11% | +65.3% |
| Q3 2014 | $21,531,000 | – | 699,460 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|